A study of the safety and immunogenicity of a new vaccine for the prevention of COVID-19 based on virus-like particles in phase I clinical trials - PDF (English)
Copyright (c) 2025 Grebennikova T.V., Zaykova O.N., Plotnikov A.A., Kostina L.V., Chernoryzh Y.Y., Eliseeva O.V., Latyshev O.E., Larichev V.F., Fedyakina I.T., Losich M.A., Kirillov I.M., Filatov I.E., Balandina M.V., Tsibezov V.V., Yurlov K.I., Lesnova E.I., Kondratieva V.M., Kozlova A.A., Baranets M.S., Gintsburg A.L.
This work is licensed under a Creative Commons Attribution 4.0 International License.